Академический Документы
Профессиональный Документы
Культура Документы
2
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
3
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
4
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Details of principal business activities contributing 10% or more of total turnover of company [Table] ..(1)
Unless otherwise specified, all monetary values are in INR
Product/service 1
Principal business activities of company [Axis]
[Member]
01/04/2018
to
31/03/2019
Details of principal business activities contributing 10% or more of total turnover of company [Abstract]
Details of principal business activities contributing 10% or more of total turnover of company
[LineItems]
Name of main product/service Hospital Activities
Description of main product/service Hospital Activities
NIC code of product/service 86100
Percentage to total turnover of company 100.00%
5
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Your Directors
have pleasure to present
their 8thAnnual Report
and the Audited Financial
Disclosure in board of directors report explanatory [TextBlock] Statements for the
financial year ended
31stMarch,
2019
There was no
Disclosure for companies covered under section 178(1) on change in the board of
directors appointment and remuneration including other matters directors of the company
provided under section 178(3) [TextBlock] during the year under
review.
6
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
There is no
Change in the nature of the
Disclosure of change in nature of business [TextBlock] business of the Company
during the
year.
N o t
Applicable
Details of directors or key managerial personnels who were
appointed or have resigned during year [TextBlock]
7
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Your company has not accepted any deposits from public as envisaged under Section 73 to 76 of the Companies Act, 2013 read with Companies
(Acceptance of Deposits) Rules, 2014.
8
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Particulars of contracts/arrangements with related parties under section 188(1) [Text Block]
The directors of the company, who are professionally qualified doctors including their relatives, have received an aggregate amount of Rs.
3,56,20,065/- towards their professional fees and Rs. 86,00,000/- towards remuneration during the year under review. Form No. AOC-2, which
forms part of the Directors' Report, is annexed to this report. .
[Pursuant to clause (h) of sub-section (3) of 134 of the Act and Rule 8(2) of the Companies (Accounts) Rules, 2014]
Form for Disclosure of particulars of contracts/arrangements entered into by the company with related parties referred to in sub section (1) of
Section 188 of the Companies Act, 2013 including certain arms length transaction under third proviso thereto.
SI.
Particulars Details
No.
Nature of Contracts/arrangements/transaction
Date on which the special resolution was passed in General meeting as required under first
proviso to Section 188
2. Details of Contracts or arrangements or transactions at Arm's length basis and in the ordinary course of business.
9
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Salient terms of the contracts or arrangements or transaction including the value, if any Rs. 1,32,52,244/-
Particulars Details
SI. No.
02 Name(s) of the related party & nature of relationship Dr. Subodh Das, Director
Salient terms of the contracts or arrangements or transaction including the value, if any Rs. 27,50,327/-
10
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
03 Name(s) of the related party & nature of relationship Dr. Prakash Chandra Dalai, Director
Salient terms of the contracts or arrangements or transaction including the value, if any Rs. 1,30,23,944/-
04 Name(s) of the related party & nature of relationship Dr. Brundaban Nahak, Director
Salient terms of the contracts or arrangements or transaction including the value, if any Rs. 28,27,640/-
05 Name(s) of the related party & nature of relationship Dr. Manoranjan Mohapatra, Director
11
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Salient terms of the contracts or arrangements or transaction including the value, if any Rs. 33,00,670/-
06 Name(s) of the related party & nature of relationship Dr. Asima Das
Salient terms of the contracts or arrangements or transaction including the value, if any Rs. 15,240/-
Salient terms of the contracts or arrangements or transaction including the value, if any Rs. 4,50,000/-
12
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Disclosure of extract of annual return as provided under section 92(3) [Text Block]
Form No. MGT-9
[Pursuant to Section 92(3) of the Companies Act, 2013 and Rule 12(1) of the Companies (Management and Administration) Rules, 2014]
i)CIN-: U 8 5 1 1 0 O R 2 0 1 1 P T C 0 1
3 8 0 3
A N D K I D N E Y C A R E
P R I V A T E L I M I T E D
1. Public Company ( )
13
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
2. Private Company ( v )
1. Government Company ( )
2. Small Company ( )
5. NBFC ( )
6. Guarantee Company ( )
7. Limited By Share (v )
8. Unlimited Company ( )
Address P L O T N O - 1 4 6 0 / 6 1
N - 1 , I R C V I L L A G E
N A Y A P A L L I
Town/ City B H U B A N E S W A R
14
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Fax Number
E-Mail Address i g k c h o s p i t a l @ g m a i l . c o m
Web Site:
vii) Name, address, and contract details of registrar and transfer agent, if any-: N.A.
Name
Address
Town/ City
15
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Fax Number
E-Mail Address
All the business activities contributing 10% or more of the total turnover of the company shall be stated:-
SL No. Name and Description of Main Products/ Services NIC Code of the Product/ Services % to total turnover of the company
Sl. No. Name and Address of the Company CIN/GLN Holding/ Subsidiary/ Associate % of Shares Held Applicable Section
-
1. - - - -
-
2. - - - -
16
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Total Equity)
% of
Dem Total
% of % of Share
Demat Physical Total Total at Physical Total total
Shares Shares
A. Promoters
(1) Indian
a) Individual/ HUF
b) Central Govt.
c) State Govt.
d) Bodies corp.
15491493 15491493
16388927 16388927
e) Banks/FI 100 - 100
- - -
f) Any Other
- - - -
- - -
-
Sub-total
- -
17
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
- - - - - -
(A) (1)
- -
- - - - - -
- -
(2)Foreign
- - - - - -
- -
- - - - - -
(a) NRIs-
16388927 16388927
Individuals
15491493 15491493 100 - 100 -
(b)Other
Individuals
- -
- - - - - -
(c)Bodies
- -
Corp.
- - - - - -
(d)Banks/FI
- -
- - - - - -
(e)Any other
- -
- - - - - -
Sub-Total
- -
- - - - - -
(A) (2):-
- -
- - - - - -
Total Share Holding of Promoter (A)=
(A)(1)+(A)(2)
- -
- - - - - -
B. Public Shareholding
16388927 16388927
15491493 15491493 100 - 100 -
(1)Institutions
(a)Mutual
Funds
- -
(b)Banks/FI
- - - - - -
(c)Central
- -
- - - - - -
Govt
- -
- - - - - -
(d)St (d) State
- -
Govt(s)
- - - - - -
(e) Venture
- -
- - - - - -
Capital
Funds (f)Insurance
- -
- - - - - -
Companies
- -
(g) FIIS
- - - - - -
- -
(h) Foreign
- - - - - -
Venture
- -
Capital funds
- - - - - -
(j)Others
- -
18
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
(Specify) - - - - - -
corporate
- -
i)Indian
- - - - - -
(ii) Overseas (b)Individuals
(i) Individual
Shareholders
- -
Holding - - - - - -
nominal
- -
(ii)Individual Share holders
holding nominal share capital in excess of - - - - - -
Rs. 1 Lakh.
c)Others (Specify)
- -
- - - - - -
Sub- Total(B)(2):-Total public Shareholding
- -
(B)=(B)(1)+(B)(2)
- - - - - -
(C)Shares
16388927 16388927
Held by Nil
15491493 15491493 100 - 100
Custodian for
% of shares
% of Shares pledged/
Pledged/ % changes in share
% of total Share of No of % of total shares
No of shares holding during the
the Company shares of the company encumber
encumber to to total year
19
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Kedar Nath
1 35,72,488 23.06 - 37,39,154 22.82 - (0.24)
Panda
Brudaban
2 29,97,222 19.35 - 31,25,427 19.07 - (0.28)
Nahak
Subodh
3 31,47,222 20.32 - 33,13,888 20.22 - (0.10)
Kumar Das
Sukanto
4. 3,13,555 2.02 - 4,41,760 2.70 - 0.68
Kishore Das
Prakash
5. 27,05,888 17.47 - 28,34,093 17.30 - (0.17)
Chandra Dalai
Nitish Kumar
6. 8,000 0.05 - 8,000 0.05 - -
Mohanty
Manoranjan
7. 8,69,444 5.61 - 10,23,290 6.24 - (0.63)
Mohapatra
Kshistish
8. Chandra 4,44,444 2.87 - 4,44,444 2.71 - (0.16)
Mishra
Rabindranath
9. 3,66,600 2.37 - 3,66,600 2.24 - (0.13)
Tripathy
Amulya
10. 4,11,077 2.65 - 4,36,718 0.86 - (1.79)
Kumar Panda
Pradeep
11. Kumar 1,41,666 0.91 - 1,41,666 2.66 - 1.75
Mishra
Abhay Kumar
12. 2,77,777 1.79 - 2,77,777 1.69 - (0.10)
Sahoo
Laxmidhar
13. 69,444 0.45 - 69,444 0.42 - (0.03)
Parhi
Jitendra
14. 1,66,666 1.08 - 1,66,666 1.02 - (0.06)
Kumar Panda
20
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
1,54,91,493 1,54,91,493
At the beginning of the year 100 100
At the end of the year (or on the date of separation, 1,63,88,927 1,63,88,927
100 100
if separated during the year
V) Share Holding Pattern of the Top Ten Shareholders (other than Directors, Promoters and Holders of GDRs and ADRs):-
21
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
FOR EACH OF THE Directors / Key Managerial % of total shares of the No of each % of total shares
No of Shares
Person company shares of the company
1,32,92,264 1,32,92,264
At the beginning of the year 81.10 81.10
7,43,588
4.54 1,40,35,852
1. Increase by way of allotment of Equity Shares on
17/05/2019 4.54
VII. INDEBTNESS-:
Indebtedness of the company including interest outstanding/ accrued but not due for payment
1) Principal Amount
not paid - - - -
3)Interest accrued
- - - -
22
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
� Addition
- -
11,00,36,572.52 11,00,36,572.52 -
� Reduction
- -
15,69,42,000.52 15,69,42,000.52
Total (i+ii+iii) - -
(Managing Director)
In Rs.
In Rs.
Gross salary
23
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
provisions contained
the Income-tax
Act, 1961
1.
(b) Value of perquisites u/s
- -
17(2) Income- tax Act,
1961
- -
(c) Profits in lieu of salary
2.
Stock Option - -
3.
Sweat Equity - -
Commission
- as % of profit
- -
4.
- others, specify
- -
5.
Others, Professional Fees 1,32,52,244.00 1,32,52,244.00
Total Amount
Sl. No Particulars of Remuneration Name of Directors
24
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
In Rs.
1. Independent Directors
- - - -
(a) Fee for attending board committee meetings
(b) Commission
- - - -
(c) Others, please specify
- - - -
Total (1)
- - - -
Total (2)
35,27,640 34,50,327 1,42,23,944 2,12,01,911
25
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
1. Independent Directors
- - -
(d) Fee for attending board committee meetings
(e) Commission
- - -
(f) Others, please specify
- - -
Total (1) - - -
Sl Key Managerial
Particulars of Remuneration
No Personnel
26
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
5,92,500 6,07,500
Gross Salary
- -
-
2. Stock Option -
3. Sweat Equity - -
Commission
4. -as % of profit - -
-Others, specify
5,92,500 6,07,500
Total 15,000
Authority
Details of Penalty/
Section of the Companies Brief Appeal made, if any Give
TYPES [RD/NCLT/
Act Description punishment/ compounding fees Details)
imposed
Court]
A. Company
27
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Penalty - - - - -
Punishment - - - - -
Compounding - - - - -
B. Directors
Penalty - - - - -
Punishment - - - - -
C. Other Officer in
Default
Penalty - - - - -
Punishment - - - - -
Compounding - - - - -
Disclosure of statement on development and implementation of risk management policy [Text Block]
The company identifies and assesses various risks related to key business and strategic objectives. All the identified risks are monitored and
addresses regularly based on their severity impact and all major risks are systematically mitigated and reviewed on a continuous basis
28
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Details regarding adequacy of internal financial controls with reference to financial statements [Text Block]
The Company has in place adequate internal financial control with reference to financial statement. During the year under review, such controls
were tested and no reportable material weaknesses in the design or operation were observed.
29
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
30
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Disclosure of auditor's qualification(s), reservation(s) or adverse remark(s) in auditors' report [Table] ..(1)
Unless otherwise specified, all monetary values are in INR
Auditor's
Auditor's qualification(s), reservation(s) or adverse remark(s) in auditors' report [Axis] favourable remark
[Member]
01/04/2018
to
31/03/2019
Disclosure of auditor's qualification(s), reservation(s) or adverse remark(s) in auditors' report [Abstract]
Disclosure of auditor's qualification(s), reservation(s) or adverse remark(s) in auditors' report
[LineItems]
(i) In respect of its
Disclosure in auditors report relating to fixed assets fixed assets:
(a) The Company
has maintained
proper records
showing full
Disclosure relating to quantitative details of fixed assets particulars, including
quantitative details
and situation of fixed
assets.
Textual information
Disclosure relating to physical verification and material discrepancies of fixed assets (10) [See below]
Textual information
Disclosure relating to title deeds of immovable properties (11) [See below]
Textual information
Disclosure in auditors report relating to inventories (12) [See below]
Textual information
Disclosure in auditors report relating to loans (13) [See below]
Disclosure about loans granted to parties covered under section 189 of companies act NA
Disclosure relating to terms and conditions of loans granted NA
Disclosure regarding receipt of loans granted NA
Disclosure regarding terms of recovery of loans granted NA
Textual information
Disclosure in auditors report relating to compliance with Section 185 and 186 of Companies Act, 2013 (14) [See below]
Textual information
Disclosure in auditors report relating to deposits accepted (15) [See below]
Textual information
Disclosure in auditors report relating to maintenance of cost records (16) [See below]
Textual information
Disclosure in auditors report relating to statutory dues [TextBlock] (17) [See below]
Textual information
Disclosure relating to regularity in payment of undisputed statutory dues [TextBlock] (18) [See below]
Textual information
Disclosure relating to disputed statutory dues [TextBlock] (19) [See below]
(viii) In our opinion
and according to the
information and
explanations given
to us, the Company
Disclosure in auditors report relating to default in repayment of financial dues has not defaulted in
the repayment of
dues to financial
institutions, banks
and debenture
holders
Disclosure in auditors report relating to public offer and term loans used for purpose for which Textual information
those were raised (20) [See below]
Disclosure in auditors report relating to fraud by the company or on the company by its officers Textual information
or its employees reported during period (21) [See below]
Textual information
Disclosure in auditors report relating to managerial remuneration (22) [See below]
(xii) In our opinion
and according to the
information and
explanations given
to us, the Company
Disclosure in auditors report relating to Nidhi Company is not a nidhi
company.
Accordingly,
paragraph 3(xii) of
the Order is not
applicable.
Textual information
Disclosure in auditors report relating to transactions with related parties (23) [See below]
31
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Disclosure in auditors report relating to preferential allotment or private placement of shares or Textual information
convertible debentures (24) [See below]
Disclosure in auditors report relating to non-cash transactions with directors or persons connected Textual information
with him (25) [See below]
(xvi) The Company
is not required to be
Disclosure in auditors report relating to registration under section 45-IA of Reserve Bank of India registered under
Act, 1934 section 45-IA of the
Reserve Bank of
India Act 1934
Disclosure in auditors report relating to compliance with Section 185 and 186 of Companies Act, 2013
(iv) In our opinion and according to information and explanation given to us, the company has not granted any loans or provided any guarantees
or given any security or made any investments to which the provision of section 185 and 186 of the Companies Act, 2013. Accordingly,
paragraph 3 (iv) of the order is not applicable.
32
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Disclosure in auditors report relating to public offer and term loans used for purpose for which those were raised
(ix) In our opinion and according to the information and explanations given to us, the Company raised money by way of term loan and further
issue of share capital were applied for the purpose for which they were raised
Disclosure in auditors report relating to fraud by the company or on the company by its officers or its employees
reported during period
(x) To the best of our knowledge and according to the information and explanations given to us, no fraud by the Company and no material fraud
on the Company has been noticed or reported during the year
33
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Disclosure in auditors report relating to preferential allotment or private placement of shares or convertible
debentures
According to the information and explanations give to us and based on our examination of the records of the Company, the Company has made
private placement of 8,97,434 Nos. equity shares of `10/- each at a premium of `29/- per share during the year
Disclosure in auditors report relating to non-cash transactions with directors or persons connected with him
(xv) According to the information and explanations given to us and based on our examination of the records of the Company, the Company has
not entered into non-cash transactions with directors or persons connected with him. Accordingly, paragraph 3(xv) of the Order is not applicable
34
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Opinion
We have audited the accompanying financial statements of INSTITUTE OF GASTRO & KIDNEY CARE PRIVATE LIMITED ("the
Company"), which comprise the balance sheet as at March 31, 2019, the Statement of Profit and Loss and statement of cash flows for the year
then ended, and notes to the financial statements, including a summary of significant accounting policies and other explanatory information.
In our opinion and to the best of our information and according to the explanations given to us, the aforesaid financial statements give the
information required by the Companies Act, 2013 ('Act') in the manner so required and give a true and fair view in conformity with the
accounting principles generally accepted in India, of the state of affairs of the Company as at March 31, 2019, its profit and cash flows for the
year ended on that date.
We conducted our audit in accordance with the standards on auditing specified under section 143 (10) of the Companies Act, 2013. Our
responsibilities under those Standards are further described in the auditor's responsibilities for the audit of the financial statements section of our
report. We are independent of the Company in accordance with the code of ethics issued by the Institute of Chartered Accountants of India
together with the ethical requirements that are relevant to our audit of the financial statements under the provisions of the Act and the rules there
under, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the code of ethics.
We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
The Company's Board of Directors is responsible for the matters stated in Section 134(5) of the Companies Act, 2013("the Act") with respect to
the preparation of these financial statements that give a true and fair view of the financial position, financial performance and Cash Flow of the
Company in accordance with the accounting principles generally accepted in India, including the Accounting Standards specified under Section
133 of the Act, read with Rule 7 of the Companies (Accounts) Rules, 2014.
This responsibility also includes the maintenance of adequate accounting records in accordance with the provision of the Act for safeguarding of
the assets of the Company and for preventing and detecting the frauds and other irregularities; selection and application of appropriate accounting
policies; making judgments and estimates that are reasonable and prudent; and design, implementation and maintenance of adequate internal
financial controls, that were operating effectively for ensuring the accuracy and completeness of the accounting records, relevant to the
preparation and presentation of the financial statements that give a true and fair view and are free from material misstatement, whether due to
fraud or error.
In preparing the Financial statements, Management is responsible for assessing the company's ability to continue as going concern, disclosing, as
applicable, matters related to Going concern and using the going concern basis of accounting unless management either intends to liquidate to the
company or to cease the operations, or has no realistic alternative but to do so.
The Board of Director's are also responsible for overseeing the company's financial reporting process.
35
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether
due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a
guarantee that an audit conducted in accordance with SAs will always detect a material misstatement when it exists. Misstatements can arise from
fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic
decisions of users taken on the basis of these financial statements.
As part of an audit in accordance with SAs, we exercise professional judgment and maintain professional skepticism throughout the audit. We
also:
Identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, design and perform audit
procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not
detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery,
intentional omissions, misrepresentations, or the override of internal control. Obtain an understanding of internal control relevant to the audit in
order to design audit procedures that are appropriate in the circumstances. Under section 143(3)(i) of the Companies Act, 2013, we are also
responsible for expressing our opinion on whether the company has adequate internal financial controls system in place and the operating
effectiveness of such controls Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related
disclosures made by management. Conclude on the appropriateness of management's use of the going concern basis of accounting and, based on
the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the Company's
ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor's report to
the related disclosures in the financial statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the
audit evidence obtained up to the date of our auditor's report. However, future events or conditions may cause the company to cease to continue as
a going concern. Evaluate the overall presentation, structure and content of the financial statements, including the disclosures, and whether the
financial statements represent the underlying transactions and events in a manner that achieves fair presentation .
We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant
audit findings, including any significant deficiencies in internal control that we identify during our audit.
We also provide those charged with governance with a statement that we have complied with relevant ethical requirements regarding
independence, and to communicate with them all relationships and other matters that may reasonably be thought to bear on our independence, and
where applicable, related safeguards.
From the matters communicated with those charged with governance, we determine those matters that were of most significance in the audit of
the financial statements of the current period and are therefore the key audit matters. We describe these matters in our auditor's report unless law
or regulation precludes public disclosure about the matter or when, in extremely rare circumstances, we determine that a matter should not be
communicated in our report because the adverse consequences of doing so would reasonably be expected to outweigh the public interest benefits
of such communication.
1. As required by the Companies (Auditor's Report) Order, 2016 ("the Order") issued by the Central Government in terms of Section 143 (11) of
the Act, we give in theAnnexure-Astatement on the matter specified in paragraphs 3 and 4 of the Order.
(a) We have sought and obtained all the information and explanations which to the best of our knowledge and belief were necessary for the
purposes of our audit.
(b) In our opinion, proper books of account as required by law have been kept by the Company so far as it appears from our examination of
those books.
(c) The Balance Sheet, the Statement of Profit and Loss and the Cash Flow Statement dealt with by this Report are in agreement with the books
of account.
36
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
(d) In our opinion, the aforesaid financial statements comply with the Accounting Standards specified under Section 133 of the Act, read with
Rule 7 of the Companies (Accounts) Rules, 2014.
(e) On the basis of the written representations received from the directors as on 31 March, 2019 taken on record by the Board of Directors, none
of the directors is disqualified as on 31 March, 2018 from being appointed as a director in terms of Section 164 (2) of the Act.
(f) Since the Company's turnover as per last audited financial statements is less than ` 50 Crores and its borrowings from banks and financial
institutions at any time during the year is less than ` 25 crores, the company is exempted from getting an audit opinion with respect to the
adequacy of the internal financial controls over financial reporting of the company and the operating effectiveness of such control vide
Notification No. G.S.R. 464(E) dated June 13,2017
(g) With respect to the other matters to be included in the Auditor's Report in accordance with Rule 11 of the Companies (Audit and Auditors)
Rule, 2014, in our opinion and to the best of our information and according to the explanations given to us
i) The Company does not have any pending litigation which would impact its financial position;
ii) The Company did not have any long-term contracts including derivative contracts for which there were any material foreseeable losses;
iii) There were no amounts which required to be transferred to the Investor Education and Protection Fund by the Company.
37
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
38
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
39
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
40
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Disclosure of shareholding more than five per cent in company [Table] ..(1)
Unless otherwise specified, all monetary values are in INR
Classes of share capital [Axis] Equity shares 1 [Member]
Name of shareholder [Axis] Shareholder 1 [Member] Shareholder 2 [Member]
01/04/2018 01/04/2017 01/04/2018 01/04/2017
to to to to
31/03/2019 31/03/2018 31/03/2019 31/03/2018
Disclosure of shareholding more than five per cent in
company [Abstract]
Disclosure of shareholding more than five per cent
in company [LineItems]
Type of share ORDINARY ORDINARY ORDINARY ORDINARY
KEDAR NATH KEDAR NATH BRUNDABAN BRUNDABAN
Name of shareholder PANDA PANDA NAHAK NAHAK
PAN of shareholder ALUPP7287R ALUPP7287R ACBPN4528K ACBPN4528K
Country of incorporation or residence of
INDIA INDIA INDIA INDIA
shareholder
Number of shares held in company [shares] 37,39,154 [shares] 35,72,488 [shares] 31,25,427 [shares] 29,97,222
Percentage of shareholding in company 23.00% 23.00% 19.00% 19.00%
41
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Disclosure of shareholding more than five per cent in company [Table] ..(2)
Unless otherwise specified, all monetary values are in INR
Classes of share capital [Axis] Equity shares 1 [Member]
Name of shareholder [Axis] Shareholder 3 [Member] Shareholder 4 [Member]
01/04/2018 01/04/2017 01/04/2018 01/04/2017
to to to to
31/03/2019 31/03/2018 31/03/2019 31/03/2018
Disclosure of shareholding more than five per cent in
company [Abstract]
Disclosure of shareholding more than five per cent
in company [LineItems]
Type of share ORDINARY ORDINARY ORDINARY ORDINARY
SUBODH KUMAR SUBODH KUMAR P R A K A S H PRAKASH
Name of shareholder DAS DAS CHANDRA DALAI CHANDRA DALAI
PAN of shareholder AHSPD2066J AHSPD2066J AIIPD0686R AIIPD0686R
Country of incorporation or residence of
INDIA INDIA INDIA INDIA
shareholder
Number of shares held in company [shares] 33,13,888 [shares] 31,47,222 [shares] 28,34,093 [shares] 27,05,888
Percentage of shareholding in company 20.00% 20.00% 17.00% 17.00%
Disclosure of shareholding more than five per cent in company [Table] ..(3)
Unless otherwise specified, all monetary values are in INR
Classes of share capital [Axis] Equity shares 1 [Member]
Name of shareholder [Axis] Shareholder 5 [Member]
01/04/2018 01/04/2017
to to
31/03/2019 31/03/2018
Disclosure of shareholding more than five per cent in company [Abstract]
Disclosure of shareholding more than five per cent in company [LineItems]
Type of share ORDINARY ORDINARY
MANORANJAN MANORANJAN
Name of shareholder MOHAPATRA MOHAPATRA
PAN of shareholder ADRPM3649R ADRPM3649R
Country of incorporation or residence of shareholder INDIA INDIA
Number of shares held in company [shares] 10,23,290 [shares] 8,69,444
Percentage of shareholding in company 6.00% 6.00%
42
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
43
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
44
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
45
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
46
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
47
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
48
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
49
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
50
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
51
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
52
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
53
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
54
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
55
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
56
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
57
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
58
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
59
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
60
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
61
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
62
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
63
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
64
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
65
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
66
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
67
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
68
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
69
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
70
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Derivative assets 0 0
Tangible assets held for sale 0 0
Other current assets, others 76,35,171 79,06,684
Total other current assets 86,83,768.97 82,80,472
TDS, advance TDS, advance
Nature of other current assets tax, security deposit tax, security deposit
Share other current assets joint ventures 0 0
71
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
72
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
[200800] Notes - Disclosure of accounting policies, changes in accounting policies and estimates
Unless otherwise specified, all monetary values are in INR
01/04/2018 01/04/2017
to to
31/03/2019 31/03/2018
Disclosure of accounting policies, change in accounting policies and Textual information (27) Textual information (28)
changes in estimates explanatory [TextBlock] [See below] [See below]
Textual information (29) Textual information (30)
Disclosure of general information about company [TextBlock] [See below] [See below]
Textual information (31) Textual information (32)
Disclosure of accounting policies explanatory [TextBlock] [See below] [See below]
73
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Disclosure of accounting policies, change in accounting policies and changes in estimates explanatory [Text Block]
Notes to Financial Statements for the Year ended 31stMarch, 2019 .
1. A. COMPANY INFORMATION.
INSTITUTE OF GASTRO & KIDNEY CARE PRIVATE LIMITED is a private limited company domiciled in India. The company is engaged
in providing medical & healthcare services.
The financial statements have been prepared to comply with the Generally Accepted Accounting Principles in India (Indian GAAP) including the
Accounting Standards notified under the relevant provisions of the Companies Act, 2013.
These statements have been prepared on accrual basis under the historical cost convention.
b) Valuation of Inventories
c) Fixed Assets
Fixed Assets are stated at cost of acquisition and subsequent improvement thereto. The cost of acquisition includes taxes, duties, freight and other
expenses related to acquisition and installation.
d) Depreciation
Depreciation on fixed assets has been provided as per Schedule II of the Companies Act, 2013 on the basis of WDV method.
Material events occurring after the Balance Sheet date are taken in cognizance.
f) Treatment of Contingencies
g) Employee Benefits
74
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
h) Previous Year
Previous year figures are regrouped and rearranged wherever necessary to conform to current year's presentation in the financial statements.
75
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Disclosure of accounting policies, change in accounting policies and changes in estimates explanatory [Text Block]
Notes to Financial Statements for the Year ended 31stMarch, 2018 .
1. A. COMPANY INFORMATION.
INSTITUTE OF GASTRO & KIDNEY CARE PRIVATE LIMITED is a private limited company domiciled in India. The company is engaged
in providing medical & healthcare services.
The financial statements have been prepared to comply with the Generally Accepted Accounting Principles in India (Indian GAAP) including the
Accounting Standards notified under the relevant provisions of the Companies Act, 2013.
These statements have been prepared on accrual basis under the historical cost convention.
b) Valuation of Inventories
c) Fixed Assets
Fixed Assets are stated at cost of acquisition and subsequent improvement thereto. The cost of acquisition includes taxes, duties, freight and other
expenses related to acquisition and installation.
d) Depreciation
Depreciation on fixed assets has been provided as per Schedule II of the Companies Act, 2013 on the basis of WDV method.
Material events occurring after the Balance Sheet date are taken in cognizance.
f) Treatment of Contingencies
g) Employee Benefits
76
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
h) Previous Year
Previous year figures are regrouped and rearranged wherever necessary to conform to current year's presentation in the financial statements.
77
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
The financial statements have been prepared to comply with the Generally Accepted Accounting Principles in India (Indian GAAP) including the
Accounting Standards notified under the relevant provisions of the Companies Act, 2013.
These statements have been prepared on accrual basis under the historical cost convention.
b) Valuation of Inventories
c) Fixed Assets
Fixed Assets are stated at cost of acquisition and subsequent improvement thereto. The cost of acquisition includes taxes, duties, freight and other
expenses related to acquisition and installation.
d) Depreciation
Depreciation on fixed assets has been provided as per Schedule II of the Companies Act, 2013 on the basis of WDV method.
Material events occurring after the Balance Sheet date are taken in cognizance.
f) Treatment of Contingencies
g) Employee Benefits
h) Previous Year
Previous year figures are regrouped and rearranged wherever necessary to conform to current year's presentation in the financial statements.
78
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
The financial statements have been prepared to comply with the Generally Accepted Accounting Principles in India (Indian GAAP) including the
Accounting Standards notified under the relevant provisions of the Companies Act, 2013.
These statements have been prepared on accrual basis under the historical cost convention.
b) Valuation of Inventories
c) Fixed Assets
Fixed Assets are stated at cost of acquisition and subsequent improvement thereto. The cost of acquisition includes taxes, duties, freight and other
expenses related to acquisition and installation.
d) Depreciation
Depreciation on fixed assets has been provided as per Schedule II of the Companies Act, 2013 on the basis of WDV method.
Material events occurring after the Balance Sheet date are taken in cognizance.
f) Treatment of Contingencies
g) Employee Benefits
h) Previous Year
Previous year figures are regrouped and rearranged wherever necessary to conform to current year's presentation in the financial statements.
79
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
80
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
81
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
82
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
83
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
84
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
85
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
86
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
87
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
88
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
89
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Guarantee commission 0 0
Cost repairs maintenance other assets 0 0
Cost transportation [Abstract]
Cost freight 0 0
Cost octroi 0 0
Cost loading and unloading 0 0
Cost other transporting 0 0
Total cost transportation 0 0
Cost lease rentals 0 0
Cost effluent disposal 0 0
Provision for cost of restoration 0 0
Cost warehousing 0 0
Cost water charges 0 0
Cost technical services 0 0
Cost royalty 0 0
Provision bad doubtful debts created 0 0
Provision bad doubtful loans advances created 0 0
Adjustments to carrying amounts of investments [Abstract]
Provision diminution value current investments created 0 0
Provision diminution value long-term investments created 0 0
Total adjustments to carrying amounts of investments 0 0
Net provisions charged [Abstract]
Provision warranty claims created 0 0
Provision statutory liabilities created 0 0
Provision restructuring created 0 0
Other provisions created 0 0
Total net provisions charged 0 0
Discount issue shares debentures written off [Abstract]
Discount issue shares written off 0 0
Discount issue debentures written off 0 0
Total discount issue shares debentures written off 0 0
Write-off assets [Abstract]
Miscellaneous expenditure written off [Abstract]
Financing charges written off 0 0
Voluntary retirement compensation written off 0 0
Technical know-how written off 0 0
Other miscellaneous expenditure written off 0 0
Total miscellaneous expenditure written off 0 0
Fixed assets written off 0 0
Inventories written off 0 0
Investments written off 0 0
Bad debts written off 0 0
Bad debts advances written off 0 0
Other assets written off 0 0
Total write-off assets 0 0
Loss on disposal of intangible asset 0 0
Loss on disposal, discard, demolishment and destruction of depreciable
0 0
tangible asset
Contract cost [Abstract]
Site labour supervision cost contracts 0 0
Material cost contract 0 0
Depreciation assets contracts 0 0
Cost transportation assets contracts 0 0
Hire charges assets contracts 0 0
Cost design technical assistance contracts 0 0
Warranty cost contracts 0 0
Other claims contracts 0 0
Sale material scrap other assets contracts 0 0
Overhead costs apportioned contracts [Abstract]
Insurance cost apportioned contract 0 0
Design technical assistance apportioned contracts 0 0
Other overheads apportioned contracts 0 0
Total overhead costs apportioned contracts 0 0
Total contract cost 0 0
Cost dry wells 0 0
90
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
91
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
92
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
[300700] Notes - Key managerial personnels and directors remuneration and other information
Disclosure of key managerial personnels and directors and remuneration to key managerial personnels and directors [Table] ..(1)
Unless otherwise specified, all monetary values are in INR
Key managerial personnels and directors [Axis] DIRECTOR1 DIRECTOR2 DIRECTOR3 DIRECTOR4
01/04/2018 01/04/2018 01/04/2018 01/04/2018
to to to to
31/03/2019 31/03/2019 31/03/2019 31/03/2019
Disclosure of key managerial personnels and directors and
remuneration to key managerial personnels and directors
[Abstract]
Disclosure of key managerial personnels and directors
and remuneration to key managerial personnels and
directors [LineItems]
KEDAR NATH SUBODH KUMAR P R A K A S H BRUNDABAN
Name of key managerial personnel or director PANDA DAS CHANDRA DALAI NAHAK
Director identification number of key managerial
03519663 03529450 03529446 03519673
personnel or director
Date of birth of key managerial personnel or
08/08/1967 26/12/1971 20/07/1969 18/03/1968
director
Designation of key managerial personnel or director Director Director Director Director
Qualification of key managerial personnel or
DOCTOR DOCTOR DOCTOR DOCTOR
director
Shares held by key managerial personnel or director [shares] 37,39,154 [shares] 33,13,888 [shares] 28,34,093 [shares] 31,25,427
Key managerial personnel or director remuneration
[Abstract]
Gross salary to key managerial personnel or
director [Abstract]
Salary key managerial personnel or director 48,00,000 7,00,000 12,00,000 7,00,000
Gross salary to key managerial personnel or
48,00,000 7,00,000 12,00,000 7,00,000
director
Total key managerial personnel or director
48,00,000 7,00,000 12,00,000 7,00,000
remuneration
93
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Disclosure of key managerial personnels and directors and remuneration to key managerial personnels and directors [Table] ..(2)
Unless otherwise specified, all monetary values are in INR
Key managerial personnels and directors [Axis] DIRECTOR5 DIRECTOR6 KMP1 KMP2
01/04/2018 01/04/2018 01/04/2018 01/04/2018
to to to to
31/03/2019 31/03/2019 31/03/2019 31/03/2019
Disclosure of key managerial personnels and directors and
remuneration to key managerial personnels and directors
[Abstract]
Disclosure of key managerial personnels and directors
and remuneration to key managerial personnels and
directors [LineItems]
MANORANJAN SUJATA PADMA CHARAN
Name of key managerial personnel or director MOHAPATRA TRIPATHY PANDA
SUJATA BEHERA
94